Mode
Text Size
Log in / Sign up

Systematic review suggests specific probiotic strains may influence sex hormone related disorders

Systematic review suggests specific probiotic strains may influence sex hormone related disorders
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
Key Takeaway
Note that specific probiotic strains may assist in managing hormonal imbalances and inflammation via the gut-hormone axis.

This systematic review explores the relationship between probiotics and sex hormone related disorders. The authors focus on the regulatory mechanisms of the bidirectional axis between the gut microbiota and sex hormones, noting that dysregulation of this axis is a critical factor in the pathogenesis of these conditions.

The synthesis of available evidence indicates that specific probiotic strains may provide therapeutic benefits. The authors report that these strains may ameliorate hormonal imbalances, attenuate inflammation, and optimize metabolic parameters. These findings suggest that probiotics could serve as a promising adjunctive therapeutic strategy by targeting the gut microbiota-sex hormone axis.

While the review highlights potential benefits for hormonal, inflammatory, and metabolic health, the specific strains, dosages, and clinical outcomes were not reported in detail within the provided data. The clinical relevance of these findings lies in the potential for adjunctive management of sex hormone related disorders through microbiota modulation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Sex hormone related disorders, characterized by complex etiology and long-term health risks, pose a significant challenge to global health. Hormone-based therapies are often accompanied by adverse effects and fail to address the underlying pathophysiological mechanisms. The “gut microbiota-sex hormone axis” maintains endocrine homeostasis through diverse pathways, including enzymatic reactions, immune modulation, metabolic regulation, and the microbiome-gut-brain axis. Dysregulation of this axis has been identified as a critical factor in the pathogenesis of sex hormone-related disorders. Probiotics have emerged as a promising adjunctive therapeutic strategy by targeting this axis. Preclinical and clinical studies have demonstrated that specific probiotic strains ameliorate hormonal imbalances, attenuate inflammation, and optimize metabolic parameters, showing positive efficacy in sex hormone-related disorders. This review systematically elaborates the regulatory mechanisms of this bidirectional axis and highlights the application of probiotics and its regulatory roles as targeted interventions in related disorders.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.